NEOGENOMICS INC NEO

About NEOGENOMICS INC (NEO): stock profile, AI score and financials

NEOGENOMICS INC (NEO) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores NEO at 38.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,209 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (24.4) and free cash flow (25.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 22.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), NEOGENOMICS INC reports quarterly revenue of $201.7M, net income of $2.2M, an operating margin of -4.9%. Top institutional holders of NEO by reported 13-F value include BlackRock, First Light Asset Management, FIRST ADVISORS, based on the most recent SEC filings. NEO trades on the Nasdaq exchange and files with the SEC under CIK 1077183. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NEO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEOGENOMICS INC directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1077183 →